Predictive Oncology Inc (POAI)

Apr 1, 2025, 7:00 AM EDT - 7 days ago

Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

Mar 25, 2025, 7:00 AM EDT - 14 days ago

Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary

Mar 20, 2025, 7:00 AM EDT - 19 days ago

Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries

Feb 19, 2025, 5:20 PM EST - 6 weeks ago

Predictive Oncology Closes Registered Direct Offering

Feb 18, 2025, 8:00 AM EST - 7 weeks ago

Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing

Feb 12, 2025, 2:00 PM EST - 7 weeks ago

Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform

Jan 30, 2025, 7:00 AM EST - 2 months ago

AIRNA Appoints Matthew Hawryluk as Chief Business Officer

Jan 16, 2025, 8:00 AM EST - 2 months ago

Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay

Jan 7, 2025, 6:51 PM EST - 3 months ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

RENB

Jan 6, 2025, 9:10 AM EST - 3 months ago

Predictive Oncology Announces Agreement to be Acquired by Renovaro

Nov 13, 2024, 7:00 AM EST - 5 months ago

Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update

Sep 5, 2024, 8:00 AM EDT - 7 months ago

Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 14, 2024, 12:47 PM EDT - 8 months ago

Predictive Oncology Inc. (POAI) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:00 AM EDT - 8 months ago

Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 7, 2024, 7:00 AM EDT - 8 months ago

Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

Jul 26, 2024, 8:00 AM EDT - 9 months ago

Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds

Jul 25, 2024, 7:00 AM EDT - 9 months ago

Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results

Jun 11, 2024, 8:00 AM EDT - 10 months ago

Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)

Jun 4, 2024, 8:42 AM EDT - 11 months ago

Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery

May 29, 2024, 7:00 AM EDT - 11 months ago

Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024

May 28, 2024, 7:00 AM EDT - 11 months ago

Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

May 15, 2024, 5:34 PM EDT - 11 months ago

Predictive Oncology Inc. (POAI) Q1 2024 Earnings Call Transcript

May 15, 2024, 7:00 AM EDT - 11 months ago

Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update

May 10, 2024, 7:00 AM EDT - 11 months ago

Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024

Apr 24, 2024, 4:05 PM EDT - 1 year ago

Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Apr 1, 2024, 10:25 AM EDT - 1 year ago

Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 5:28 PM EDT - 1 year ago

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update

Feb 21, 2024, 4:05 PM EST - 1 year ago

Predictive Oncology to Participate in Upcoming Investor Conferences

Jan 2, 2024, 7:00 AM EST - 1 year ago

Predictive Oncology to Participate in Upcoming San Francisco Conferences

Nov 14, 2023, 1:27 PM EST - 1 year ago

Predictive Oncology Inc. (POAI) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 7:00 AM EST - 1 year ago

Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 8, 2023, 8:12 AM EST - 1 year ago

Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital

Aug 10, 2023, 11:56 PM EDT - 1 year ago

Predictive Oncology, Inc. (POAI) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 5:15 PM EDT - 1 year ago

Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 3, 2023, 8:00 AM EDT - 1 year ago

Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023

Jul 18, 2023, 8:00 AM EDT - 1 year ago

Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh

Jun 27, 2023, 8:00 AM EDT - 1 year ago

Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board

Jun 20, 2023, 8:00 AM EDT - 1 year ago

Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board

May 23, 2023, 8:30 AM EDT - 2 years ago

Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention

May 15, 2023, 9:22 PM EDT - 2 years ago

Predictive Oncology, Inc. (POAI) Q1 2023 Earnings Conference Call Transcript

May 15, 2023, 5:15 PM EDT - 2 years ago

Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update

Apr 20, 2023, 5:10 PM EDT - 2 years ago

Predictive Oncology Announces Reverse Stock Split

Apr 17, 2023, 6:00 PM EDT - 2 years ago

Predictive Oncology Adjourns Special Meeting of Stockholders

Apr 4, 2023, 8:30 AM EDT - 2 years ago

Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board

Mar 30, 2023, 8:30 AM EDT - 2 years ago

Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy

Mar 22, 2023, 7:05 PM EDT - 2 years ago

Predictive Oncology, Inc. (POAI) Q4 2022 Earnings Conference Call Transcript

Mar 21, 2023, 5:15 PM EDT - 2 years ago

Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update

Mar 17, 2023, 7:00 AM EDT - 2 years ago

Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs

Mar 16, 2023, 5:15 PM EDT - 2 years ago

Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock